ObesityACTION-CHNCT05232786
Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland
An observational study of Obesity, run by Novo Nordisk A/S at 1 site in Switzerland.
Trial summary
ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Obesity
- What is being tested?
- No treatment given
- How many people
- 1,152 participants
- Where
- 1 siteSwitzerland
- Study dates
- 8 Mar 2022to 8 Apr 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management
Who may be able to join
- People Living with Obesity:
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male, female or other, aged above or equal to 18 years at the time of signing informed consent
- Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
- Current BMI of 30 Kg/m^2 or greater calculated based on self-reported height and weight
- Health Care Professionals:
Show all 16Show fewer
- Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
- Male, female or other, aged above or equal to 18 years at the time of signing informed consent.
- Physician
- Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance
- Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)
- Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery
- Practices in Switzerland
- In clinical practice for greater than or equal to 2 years
- Spends at least 50% time in direct patient care
- Has seen at least 100 adult patients in past month (all physicians except psychiatrists) Has seen at least 10 patients with obesity (PCPs and General Internal Medicine with focus on Diabetes and/or obesity, Obstetrics/ Gynaecologists, Endocrinology/Diabetology or Bariatric surgery) or 5 patients with obesity (dietitians and psychiatrists) in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 Kg/m^2 with or without comorbidities.
Who cannot join
- People Living with Obesity:
- Previous participation in this study. Participation is defined as having given online consent in this study
- Currently pregnant
- Participates in intense fitness or body building programs
- Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Show all 9Show fewer
- Health Care Providers:
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
Trial locations and contacts
1 site in 1 country.
About this study
ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.
The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
- Conditions
- Obesity
- Being tested
- No treatment given
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No treatment givenOther
No treatment given
| Study group | Role | What they receive |
|---|---|---|
| People / Person Living with Obesity (PLwO) | From online, general population consumer panels Receives: Other: No treatment given | |
| Health Care Professionals (HCPs) | HCPs treating people who have obesity Receives: Other: No treatment given |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight loss motivators
Multi-select from defined list
Measured: At the time of survey response (Day 1)
Proportion of PLwO who made serious weight loss effort
Number of weight loss efforts; percentage of patients
Measured: At the time of survey response (Day 1)
Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs
5-point Likert scales (e.g., agreement, impact, frequency)
- Proportion of responses in each category will be reported.
Measured: At the time of survey response (Day 1)
Weight loss barriers
Multi-select from defined list
Measured: At the time of survey response (Day 1)
Weight loss management
Multi-select from defined list
Measured: At the time of survey response (Day 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2022
- Study start8 Mar 2022
- Primary completion8 Apr 2022
- Study completion8 Apr 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- More trials run by Novo Nordisk A/SThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 1,152 participants (actual)
Sponsor and investigators
- Lead sponsor
- Novo Nordisk A/S
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Clinical Transparency (dept. 2834), Study director, Novo Nordisk A/S
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05232786
- Sponsor's protocol ID
- DAS-005
- Other IDs
- U1111-1266-4398
- Acronym
- ACTION-CH
- Status last verified
- Oct 2022
- First submitted
- 12 Jan 2022
- Last updated
- 26 Oct 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: According to the Novo Nordisk disclosure commitment on novonordisk-trials.com
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland
- ClinicalTrials.gov ID
- NCT05232786
- Acronym / sponsor ID
- ACTION-CH / DAS-005
- Conditions
- Obesity
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,152 participants (actual)
- Lead sponsor
- Novo Nordisk A/SIndustry (pharma, biotech, devices)
- Study start
- 8 Mar 2022 (actual)
- Primary completion
- 8 Apr 2022 (actual)
- Study completion
- 8 Apr 2022 (actual)
- First posted
- 10 Feb 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor.
The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| People / Person Living with Obesity (PLwO) | – | Other: No treatment givenFrom online, general population consumer panels |
| Health Care Professionals (HCPs) | – | Other: No treatment givenHCPs treating people who have obesity |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management
Key inclusion criteria (16 listed)
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male, female or other, aged above or equal to 18 years at the time of signing informed consent
- Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
- Current BMI of 30 Kg/m^2 or greater calculated based on self-reported height and weight
- Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
Key exclusion criteria (9 listed)
- Previous participation in this study. Participation is defined as having given online consent in this study
- Currently pregnant
- Participates in intense fitness or body building programs
- Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No treatment givenNo treatment given | Other | Health Care Professionals (HCPs), People / Person Living with Obesity (PLwO) |
Primary outcome
Weight loss motivators
Time frame: At the time of survey response (Day 1)
Multi-select from defined list
Proportion of PLwO who made serious weight loss effort
Time frame: At the time of survey response (Day 1)
Number of weight loss efforts; percentage of patients
Attitudes towards obesity and weight management and Interactions of PLwOs with HCPs
Time frame: At the time of survey response (Day 1)
5-point Likert scales (e.g., agreement, impact, frequency) - Proportion of responses in each category will be reported.
Weight loss barriers
Time frame: At the time of survey response (Day 1)
Multi-select from defined list
Weight loss management
Time frame: At the time of survey response (Day 1)
Multi-select from defined list
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2022.
- Individual participant dataSharing planned: Yes. According to the Novo Nordisk disclosure commitment on novonordisk-trials.com
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Clinical Transparency (dept. 2834) study director
Novo Nordisk A/S
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Obesity, run by Novo Nordisk A/S at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 16 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight loss motivators (time frame: At the time of survey response (Day 1)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2022.